Now available the new VIASURE Dengue Virus Real Time PCR Detection Kit designed for specific identification of Dengue virus in clinical samples from patients with signs and symptoms of Dengue virus infection.
Approximately 2.5 billion people live in dengue endemic countries. In non-endemic countries, dengue is one of the causes of febrile illness among travelers returning from tropical or subtropical areas of the Caribbean, Latin America and Asia.
An estimated 50 million Dengue infections occur annually.
The majority of DENV infections are asymptomatic. The main symptoms are 2–7 days fever, accompanied by one or more of the following symptoms: headache, retro‐orbital eye pain, joint pain, muscle and/or bone pain, rash, mild bleeding manifestations and low white cell count. After the abrupt onset of the disease, three evolution phases are differentiated: febrile, critic and convalescent. During the critical phase, a fever decrease and an increase in the capillary permeability which suppose a plasma extravasation, which may conduct ascites, pleural effusions and/or fluids accumulation in a third space could be produced.
This test is intended for use as an aid in the diagnosis of the Dengue virus in combination with clinical and epidemiological risk factors.
RNA is extracted from specimens, amplified using RT-PCR and detected using fluorescent reporter dye probes specific for Dengue virus.
NOW! Shelf-life: 24 months in all our VIASURE products. Transport and storage at room temperature.